Sat.Dec 09, 2023

article thumbnail

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

Fierce Pharma

BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

article thumbnail

Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood

Pharmacy Times

The study findings have implications for the identification of novel pathways with which to selectively target folate-metabolism blood cancers.

58
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Assessing Clinical Trial Efficacy Vs Real-World Effectiveness in the Treatment of Multiple Myeloma

Pharmacy Times

The efficacy of treatments, which is the outcomes in the ideal clinical trial setting, are known to often be better than the effectiveness of those treatments, which are the outcomes of patients in the real-world setting.

article thumbnail

2023 President of the American Society of Hematology Discusses Sickle Cell Disease Treatments for the 65th ASH Annual Meeting

Pharmacy Times

The president highlights a new curative treatment option for sickle cell disease while also expanding on the changing treatment landscape for hematologic conditions.

26
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.